US 12168071
Treprostinil derivatives and their use in pharmaceutical compositions
granted A61KA61K31/495A61K31/5575
Quick answer
US patent 12168071 (Treprostinil derivatives and their use in pharmaceutical compositions) held by United Therapeutics Corporation expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/495, A61K31/5575, A61K45/06, A61K47/542